Dermata Therapeutics, Inc.
Dermata Therapeutics, Inc. is listed today as Dermata Therapeutics, Inc.: market value, financials and filings are on its company page.
Funding rounds
0 counted as startup funding, 3 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Dec 2025 | $4 M | Private placement after listing | $2 to $10 million | equity, options | SEC | |
| Jan 2025 | $3 M | Private placement after listing | $2 to $10 million | equity, options | SEC | |
| Sep 2024 | $4 M | Private placement after listing | $2 to $10 million | options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Dermata Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2026).
SEC Form D · Jan 2026
The industry group it chose in its notices: Other Technology.
SEC Form D · Jan 2026
That is all the official record says: Dermata Therapeutics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of Dermata Therapeutics, Inc. are on record.
Investors#
2 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Proehl Investment Ventures LLC | Venture capital | not stated | not stated | Held preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Wendell Wierenga | Person | not stated | not stated | Held preferred stock, director (Form 3, 2021) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.
Largest shareholders today
Institutions holding Dermata Therapeutics, Inc. shares, as of Sep 30, 2026.
- Citadel Advisors LLC$0 M0.67%
- Geode Capital Management, LLC$0 M0.41%
- Welch & Forbes LLC$0 M0.41%
- HRT Financial LP$0 M0.39%
- State Street Corp$0 M0.38%
- UBS Group AG$0 M0.35%
- Jane Street Group, LLC$0 M0.34%
- XTX Topco Ltd$0 M0.26%
- Citigroup Inc$0 M0.13%
- Vanguard Capital Management LLC$0 M0.11%
- Tower Research Capital LLC (TRC)$0 M0.01%
- SBI Securities Co., Ltd.$0 M0.00%
- Highline Wealth Partners LLC$0 M0.00%
- Jpmorgan Chase & Co$0 M0.00%
- Morgan Stanley$0 M0.00%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Christopher J. Nardo | Executive officer | Jan 2026 |
| Gerald Proehl | Executive officer | Jan 2026 |
| Kyri K. Van Hoose | Executive officer | Jan 2026 |
| Maria J. Bedoya Toro Munera | Executive officer | Jan 2026 |
| Andrew J. Sandler | Director | Jan 2026 |
| Brittany J. Bradrick | Director | Jan 2026 |
| David J. Hale | Director | Jan 2026 |
| Gerald Proehl | Director | Jan 2026 |
| Kathleen J. Scott | Director | Jan 2026 |
| Mary J. Fisher | Director | Jan 2026 |
| Steven J. Mento | Director | Jan 2026 |
| Wendell J. Wierenga | Director | Jan 2026 |
Went public since 2021. Its SEC number is that of a company listed on a stock exchange.